Pulike Bio Engineering reports declining profit; proposes cash dividend

** Pulike Bio Engineering (SSE:603566) reported a 16.77% decrease in operating revenue, totaling CNY 1.043 billion for fiscal year 2024, according to its recently released audit report. Profits attributable to shareholders decreased by 46.82% to CNY 92.81 million. The board attributed the declines to a tough competitive environment and reduced consumer spending.